Search results
Takeda Pharmaceutical: A Long-Term Cash Cow
GuruFocus.com via Yahoo Finance· 1 month agoTakeda Pharmaceutical Co. Ltd. (NYSE:TAK) is the largest Japanese pharmaceutical company and holds a leading position in the global immunoglobulins...
Takeda Pharmaceutical Co. (TAK) Upgraded to Buy: What Does It Mean for the Stock?
Zacks via Yahoo Finance· 3 months agoTakeda Pharmaceutical Co. (TAK) might move higher on growing optimism about its earnings prospects,...
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoTakeda Pharmaceutical Company Limited (NYSE:TAK) Q4 2022 Earnings Call Transcript May 11, 2023...
Better High-Yield Dividend Stock: Takeda Pharmaceutical vs. Viatris
Motley Fool· 9 months agoIf you're looking for a high-yield dividend stock in the healthcare sector, you might be interested...
Takeda Pharmaceutical Projects Lower Annual Profit After Quarterly Loss
The Wall Street Journal· 3 weeks agoHEALTH Takeda Pharmaceutical reported a fourth-quarter loss and forecast a drop in annual net profit...
Generic drugmakers start shipping copies of Takeda's ADHD drug Vyvanse
Reuters via Yahoo News· 9 months agoDrugmakers have begun shipping copycat versions of Takeda Pharmaceutical's drug Vyvanse, which is...
Japan's Takeda beats Q1 profit estimates on mainstay drugs, dengue vaccine
Reuters via Yahoo Finance· 10 months agoTOKYO (Reuters) -Japan's Takeda Pharmaceutical posted first-quarter profit that beat analysts'...
Japan's Takeda slashes full-year profit forecast on drug pipeline impairments
Reuters via Yahoo News· 7 months agoTOKYO (Reuters) -Japan's biggest drugmaker Takeda Pharmaceutical on Thursday slashed its full-year...
Is Takeda Pharmaceutical Co. (TAK) Stock Undervalued Right Now?
Zacks via Yahoo Finance· 2 years agoHere at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and...
Takeda pays $300M to license Protagonist drug for blood disorder
BioPharma Dive via Yahoo Finance· 4 months agoDive Brief: Protagonist Therapeutics, a biotechnology company focused on peptide drugs, is teaming...